in

Suven Pharma Q3 Results: Net profit surges 78% to Rs 83 crore, revenue up 40%

PE firm Advent backed Suven Pharma net profit rose 78% year-on-year (YoY) to Rs 83.3 crore in Q3FY25 compared to Rs 46.8 crore in the corresponding period of the previous year.

Revenue grew 40% YoY to Rs 307.2 crore in Q3FY25 driven by doubling of CDMO business driven by R&D and business…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Suzlon Group Partners With Karnataka Government To Develop 3,000 MW Wind Energy Project

Bharat Forge Q3 Results: Net profit falls 16% to Rs 212 cr